Cancer as an infectious disease: A different treatment alternative using a combination of tigecycline and pyrvinium pamoate – An example of breast cancer

Background: Tigecycline is an antibiotic that well tolerated for treating complicated infections. It has received attention as an anti-cancer agent and expected to solve two major obstacles, sides effects that accompany chemotherapy and drug resistance, in the breast cancer treatment. However, previ...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Shu-Wei Huang, Ming-Tsung Sun, Wen-Sen Lee, Ying-shih Su, Yi-Tzu Lee, Ming-Hsien Chiang, Yung-Chih Wang, Ya-Sung Yang, Shian-Chiuan Tzeng, Tien-Yuan Wu, Jui-Sheng Sun, Feng-Huei Lin
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Elsevier 2022-02-01
Rangatū:	Journal of Microbiology, Immunology and Infection
Ngā marau:	Breast cancer Combination therapy Pyrvinium pamoate Tigecycline
Urunga tuihono:	http://www.sciencedirect.com/science/article/pii/S1684118221000062
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!